Eli Lilly & Co. (LLY)
1058.18
+37.34
(+3.66%)
USD |
NYSE |
Feb 06, 16:00
1068.00
+9.82
(+0.93%)
After-Hours: 20:00
Eli Lilly SG&A Expense (TTM) : 11.09B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 7.05B |
| Biogen, Inc. | 2.434B |
| Gilead Sciences, Inc. | 5.886B |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Viking Therapeutics, Inc. | 52.36M |